Congratulations to Carole Hénique of Dil Sahali’s team 21 who has just published an article in Nature Communications on November 28th, 2017!
Rapidly progressive crescent glomerulonephritis (RPGN) is the most aggressive form of acquired glomerular disease. Although most therapeutic approaches use immunosuppressive strategies, pathophysiology is still a mystery. This work at the HEGP Cardiovascular Research Centre (PARCC, Team Pierre-Louis Tharaux) identified a new signaling pathway inducing the specific activation of a microRNA (miR-92a) responsible for the output of podocyte quiescence and glomerular destruction during RPGN. This article demonstrates the principle of using anti-miR as a new therapeutic strategy in this pathology (Patent issued in the US).”
Tissue damage induces a conserved stress response that initiates quiescent muscle stem cell activation :
«Philippos MOURIKIS - 13h – Videoconference Zoom»
When environmental sciences meet health sciences: 4th OSU-IMRB seminar (videoconference) :
Technical seminar on ISOPLEXIS technology :
«13h – Videoconference Teams or Zoom»
All incoming seminars